Ruth Phillips MS BSN

VP Medical Affairs at Blue Spark Technologies. Passionate about supporting patients with cancer, improving quality of life and the use of technology.

[KeloniaTx @KeloniaTx]

Today at #ASCO26 we were pleased to present additional, positive clinical data from the Phase 1 study of our investigational #InVivoCART therapy KLN-1010 in multiple myeloma.

Please find the press release with more detail on this data here: https://t.co/b6KFoKQ3dE

[KeloniaTx @KeloniaTx]

Today we are excited to announce that our team will be presenting clinical data on KLN-1010, our investigational #InVivoCART therapy, at the upcoming #ASCO26 and #EHA26 conferences. KLN-1010 has also received Fast Track designation from the FDA.

https://t.co/CmAp9cWVWw

[KeloniaTx @KeloniaTx]

Today we have entered into a definitive agreement to be acquired by Lilly. Lilly shares our bold vision to broaden accessibility of CAR T-cell therapies to ultimately reach more patients in need.

Read more in today’s press release here: https://t.co/tPfCbHasf7

[Tanya Bondar @_TanyaBondar_]

Intrigued that endogenous T-cells peak in the CNS hand-in-hand with CAR-T cells... does not prove causal T-cell autoreactivity in parkinsonism but begs the question about its potential contribution.

[BriaCell Therapeutics Corp. @BriaCell]

BriaCell announced that the independent Data Safety Monitoring Board (DSMB) has issued its sixth consecutive positive recommendation following review of safety data from BriaCell’s pivotal Phase 3 Bria-ABC study of Bria-IMT plus immune checkpoint inhibitor (CPI) in patients with #metastaticbreastcancer (NCT06072612). Find details: https://t.co/YXiB1oDga7 $BCTX $BCTXL

[Elshad Hasanov, MD, PhD @HasanovLab]

Excited to share our upcoming presentations at #ASCO2026 from the @HasanovLab @OhioStatePIIO and collaborators.
This year, our team will present 12 studies spanning:
https://t.co/jlGQZKe0vq
🤖 AI/ML precision oncology
🧠 RCC brain metastasis biology
🧫 Spatial & single-cell transcriptomics
🌎 Real-world outcomes research with ML models
💻 In silico clinical trial modeling
These projects reflect our 💻 #CodetoClinic 👩‍⚕️👨‍⚕️translational framework, integrating computational oncology, multi-omics, and clinical research to advance precision cancer care.
Grateful to our incredible trainees, collaborators, patients, and mentors who made this work possible. https://t.co/8SlON6F4d0

@OSUCCC_James @ASCOPost @ASCO @KidneyCancer @kidneycan @urotoday @OncoAlert @oncodaily @OncLive

#KidneyCancer #BrainMetastases #PrecisionOncology #AIinOncology #SpatialBiology #SingleCell #TranslationalResearch

[Hannah Goulart @HannahGoulart]

Thank you @ConquerCancerFd ! Incredibly thankful for my mentor @NitinJainMD and the support of @UTMDAnderson hematology/oncology fellowship and leukemia department! 💫 @garciamanero @ASCO

[ASH @ASH_hematology]

TCR-T therapies extend the curative promise of CAR-T therapy beyond the cell surface — uniting structural biology, tumor genomics, gene editing, immunology, and clinical hematology. Read more in The Hematologist. https://t.co/yYNS6rQqAr

[ASCO TECAG @ASCOTECAG]

🥳We’d love to spotlight trainees and early-career #oncologists presenting @ASCO #ASCO26
👉https://t.co/957TA45OYl
Share your presentations with us, and we’ll celebrate your work through posts here!👏

@NazliDizman @ja_ocejo @OncMedEdCoP @AnaVManana @oncoalert #MedEd @jrgralow @montypal @DVAraujoMD @DrBarbiOnc @LauraEsfeller @FunchainMD @YGaritaonaindia @jgong15 @DrSAHaddad @GIMedOnc @iandresmeraz @SakditadMD @RamilaShilpakar
@RohitBanwar @lungoncdoc @montypal @DrChoueiri
@neerajaiims @PGrivasMDPhD @OncoAlert @DrYukselUrun @yekeduz_emre

[Eleonora Teplinsky, MD, FASCO @drteplinsky]

Excited to be part of this panel at the Women’s Networking Center @ASCO: A Women's Networking Center Panel on Building Your Brand & Professional Identity with @ShikhaJainMD @HKlepinMD and @sdent_cardioonc! Join us ⏰ 1pm CST S502! #ASCO26

[Eleonora Teplinsky, MD, FASCO @drteplinsky]

Attending #ASCO26! Come join us Saturday 5/30 8am CST (rm S103) at the Medical Education Community of Practice meeting. I’m giving a talk called "Modern Medical Education in Oncology: Meeting Patients Where They Are." We'll be talking about social media (the good and bad), influencer culture, AI/chatbots, misinformation, and more! Hope to see you there!

[Arthi Sridhar @ASridharMD]

This is excellent and VERY timely. 👏👏

[Andy Lane @lane_andy]

Pivekimab sunirine (PVEK) approved today for #BPDCN. This is the second drug specifically approved for this rare leukemia. Great news for patients. Happy to have contributed to development of this agent over the past years with many great collaborators.
https://t.co/gl7StWi2Xk

[David Gandara @drgandara]

Wow! Impressive! Liquid biopsy "Making a Splash" at ASCO26 (so to speak) 😁 @isliquidbiopsy @ASCO

[Sneha Singh, MD @SnehaSinghMD]

Excited to share my work this upcoming week @ASCO #ASCO2026
Please come by poster board 172 - would love to connect and hear your thoughts!
Date and Time: 06/01/2026, 1:30 PM - 4:30 PM
Title: HER2-targeted tyrosine kinase inhibitors in breast cancer: Real-world analysis of gastrointestinal and musculoskeletal toxicities using the FAERS database.
Thank you @CancerExorcist for your unwavering support and mentorship!

[Ruth Phillips MS BSN @BsnRuth]

I donated $1. Please consider joining me to donate $1 to ensure nurses for tomorrow. https://t.co/qhSimORIr5

[Ruth Phillips MS BSN @BsnRuth]

Thank you ⁦@ChenyuLinMD⁩ for an excellent presentation at #ASH2025. Your work is making a difference for patients receiving CART and BiTEs. #Takeda #DukeCancerCenter #BlueSparkTechnologies

[Ruth Phillips MS BSN @BsnRuth]

Cost-conscious CAR T Delivery at ASH2025. TempTraq reduced the median length of inpatient stay by 5 days and led to a meaningful reduction in the estimated median post-infusion cost by $19,180 per patient.

[Ruth Phillips MS BSN @BsnRuth]

https://t.co/swHMRbZk0V

[touchHEMATOLOGY @touchHEMATOLOGY]

📢 Countdown to ASH25!

The 67th Annual Meeting & Exposition of the American Society of Hematology (ASH) is less than a week away! Taking place 6–9 December 2025 in Orlando, with a fully integrated virtual platform, ASH25 brings together clinicians, researchers, nurses, trainees and industry partners to explore the latest in blood science, clinical care and innovation.

👀 Follow touchHAEMATOLOGY for highlights, expert insights and daily updates throughout the meeting.

#ASH25 #Haematology #BloodCancer #ClinicalPractice #touchHAEMATOLOGY